Figure 6.
Funnel plot of comparison for PFS (A), OS (B), objective response rate (C), and disease control rate (D) between gefitinib and taxanes in NSCLC. NSCLC = nonsmall-cell lung cancer, OS = overall survival, PFS = progression-free survival.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.